InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: rafunrafun post# 289256

Sunday, 08/02/2020 9:39:34 AM

Sunday, August 02, 2020 9:39:34 AM

Post# of 423943
Raf-Skinny labeling would not be a successful method to bypass Vascepa IP...that’s the ONLY reason why I held shares through Du first case. Vascepa is still generating valid IP from USPTO....last Patent is composition & method. This patent alone would make an at risk launch direct and indirect infringement claims against ANY skinny label.
BB

If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News